SCHEMBL5770768

SCHEMBL5770768

F/C=C(/c1ccc(Cl)cc1)N1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
CHRNA7 P36544 1/20 0.42
ALDH1A1 P00352 6/20 0.41
HPGD P15428 3/20 0.41
KMT2A Q03164 3/20 0.41
LMNA P02545 3/20 0.41
RAB9A P51151 3/20 0.40
HSD11B1 P28845 3/20 0.40
MAPT P10636 2/20 0.40
AKR1C3 P42330 1/20 0.40
HTT P42858 1/20 0.40
MEN1 O00255 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 2/20 0.40
PHGDH O43175 1/20 0.40
TSHR P16473 1/20 0.40
MGLL Q99685 1/20 0.40
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5770772 1.00 SMN1; SMN2 (0.42) SMN1; SMN2CHRNA7ALDH1A1HPGDKMT2A
SCHEMBL5773227 0.81 HPGD (0.50) ALDH1A1HPGDKMT2ARAB9AHTT
SCHEMBL5773229 0.81 HPGD (0.50) ALDH1A1HPGDKMT2ARAB9AHTT
SCHEMBL4574011 0.71 SMN1; SMN2 (0.50) SMN1; SMN2CHRNA7ALDH1A1HPGDKMT2A
SCHEMBL31387921 0.71 HPGD (0.76) CHRNA7ALDH1A1HPGDKMT2ALMNA
SCHEMBL6265219 0.71 ALDH1A1 (0.68) SMN1; SMN2ALDH1A1HPGDKMT2ALMNA
SCHEMBL3455787 0.69 HPGD (0.80) CHRNA7ALDH1A1HPGDKMT2ALMNA
SCHEMBL11112400 0.69 HPGD (0.80) CHRNA7ALDH1A1HPGDKMT2ALMNA
Hydrochloric Acid SCHEMBL4034198 0.68 HPGD (0.77) CHRNA7ALDH1A1HPGDKMT2ALMNA
SCHEMBL28917068 0.68 CES2 (0.56) SMN1; SMN2CHRNA7ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed